- Home
- XPOF vs ZNTL Comparison
XPOF vs ZNTL Comparison
Compare XPOF & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPOF | ZNTL |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.2M | 156.7M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XPOF | ZNTL |
|---|---|---|
| Price | $6.01 | $2.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $8.13 | $5.80 |
| AVG Volume (30 Days) | 578.1K | ★ 585.0K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.24 | 18.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,092,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.83 | $1.01 |
| 52 Week High | $11.14 | $3.95 |
Technical Indicators
Market Signals| Indicator | XPOF | ZNTL |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 45.82 |
| Support Level | $5.91 | $1.28 |
| Resistance Level | $6.18 | $2.69 |
| Average True Range (ATR) | 0.30 | 0.19 |
| MACD | 0.11 | -0.05 |
| Stochastic Oscillator | 75.61 | 31.55 |
Price Performance
Historical ComparisonAbout XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.